Exact Sciences Announces Second Quarter 2022 Results
Second quarter highlights Total second quarter revenue of $522 million, including Screening revenue of $354 million, Precision Oncology revenue of $154...
Stay updated with breaking news from Paradigm Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Second quarter highlights Total second quarter revenue of $522 million, including Screening revenue of $354 million, Precision Oncology revenue of $154...
Mayank Taneja transitions into lead position at OSF Ventures PEORIA, Ill., June 30, 2022 /PRNewswire/ -- OSF Ventures, the corporate investment a...
Here's what to know to make sure you don't say the wrong thing to a Muslim colleague who is observing Ramadan.
Exact Sciences Corp. has acquired Marshfield-based genetic testing laboratory PreventionGenetics for $190 million.
Cardiff Oncology Announces Fourth Quarter and Full Year 2020 Results and Recent Highlights News provided by Share this article SAN DIEGO, Feb. 25, 2021 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing drugs to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorectal cancer, pancreatic cancer, castrate-resistant prostate cancer and leukemias, today announced recent company highlights and financial results for the fourth quarter and full year ended December 31, 2020. "Over the last severa...